Glioblastoma Tumor Microenvironment and Purinergic Signaling: Implications for Novel Therapies
Glial-origin brain tumors, particularly glioblastomas (GBMs), are known for their devastating prognosis and are characterized by rapid progression and fatal outcomes. Despite advances in surgical resection, complete removal of the tumor remains unattainable, with residual cells driving recurrence th...
Saved in:
| Main Authors: | Martina Bedeschi, Elena Cavassi, Antonino Romeo, Anna Tesei |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/3/385 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
miR‐373 regulates inflammatory cytokine‐mediated chondrocyte proliferation in osteoarthritis by targeting the P2X7 receptor
by: Wei Zhang, et al.
Published: (2018-03-01) -
Extracellular Vesicles and Purinergic Signaling in Alzheimer’s Disease—Joining Forces for Novel Therapeutic Approach
by: Julita Lewandowska, et al.
Published: (2025-05-01) -
Divalent metal modulation of Japanese flounder (Paralichthys olivaceus) purinergic P2X7 receptor
by: Carolina Paredes, et al.
Published: (2018-03-01) -
Graph neural networks-based prediction of drug gene association of P2X receptors in periodontal pain
by: Pradeep Kumar Yadalam, et al.
Published: (2024-05-01) -
The cellular distribution of P2X7, P2Y6, and P2Y12 during or after pilocarpine-induced status epilepticus and literature review
by: Yue Li, et al.
Published: (2024-12-01)